| | 95233-18-4 Basic information More.. |
| Product Name: | Atovaquone | | Synonyms: | 3-Hydroxy-2-[4β-(4-chlorophenyl)cyclohexan-1α-yl]naphthalene-1,4-dione;Atovaquone (200 mg);Atovaquone, USP;1,4-Naphthalenedione, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-;Atavaquone;Atovaquone for system suitability; 566C80;BW-566C | | CAS: | 95233-18-4 | | MF: | C22H19ClO3 | | MW: | 366.84 | | EINECS: | 000-000-0 | | Mol File: | 95233-18-4.mol |  |
Use
Atovaquone is an orally active antiprotozoal agent indicated for patients with mild to
moderate AIDS-associated Pneumocystis carinii pneumonia who are intolerant to the
fist-line therapy of trimethoprim-sulfamethoxazole. It is also under investigation as a
treatment for malaria and AIDS-associated toxoplasmosis.
- Atovaquone
-
- US $43.00-147.00 / mg
- 2024-11-19
- CAS:95233-18-4
- Min. Order:
- Purity: 99.85%
- Supply Ability: 10g
- Atovaquone
-
- US $43.00-147.00 / mg
- 2024-11-19
- CAS:95233-18-4
- Min. Order:
- Purity: 99.85%
- Supply Ability: 10g
- Atovaquone
-
- US $0.00 / KG
- 2024-11-14
- CAS:95233-18-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100 MT
|
|
95233-18-4
Recommend Suppliers |
|